Device-related Mycobacterium mageritense Infection in a Patient Treated with Nivolumab for Metastatic Breast Cancer

Autor:	Hironobu Minami, Yoshimi Fujishima, Sho Nishimura, Masanori Toyoda, Naomi Kiyota, Taiji Koyama, Yoshinori Imamura, Yohei Funakoshi, Hirokazu Tanino
Rok vydání:	2021
Předmět:	Tuberculosis biology business.industry Cancer General Medicine medicine.disease biology.organism_classification Mycobacterium mageritense Metastatic breast cancer Breast cancer Immunology Internal Medicine medicine Nontuberculous mycobacteria Nivolumab business Adverse effect
Zdroj:	Internal Medicine. 60:3485-3488
ISSN:	1349-7235 0918-2918
Popis:	Treatment with anti-programmed cell death-1 (PD-1) antibodies improves the anti-cancer immune response and can provide a meaningful clinical benefit to cancer patients. However, this treatment can result in specific autoimmune toxicities, termed immune-related adverse events (irAEs). Although irAEs are well recognized, the development of infectious diseases due to this treatment is not often observed. Some recent reports have indicated that patients who receive anti-PD-1 antibodies are at a higher risk for tuberculosis than others. However, reports on nontuberculous mycobacterial infection during anti-PD-1 antibody treatment are still rare. We herein report the first case of Mycobacterium mageritense infection during anti-PD-1 antibody treatment.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0da3a4f15135ed419b3a959fae17e822 https://doi.org/10.2169/internalmedicine.6550-20 Zobrazit plný text záznamu